TOP 10 COMPANIES IN VENOUS THROMBOEMBOLISM TREATMENT MARKET

The growth of this market is mainly driven by the high prevalence of venous thromboembolism, rising incidence of cancer, growing prevalence of secondary risk factors such as diabetes and obesity, increase in orthopedic surgical procedures, and the rising demand for minimally invasive treatment procedures.